ARE (are.com) יחס שווי שוק לשווי בספרים

Alexandria (ARE) owns biotech properties, facing high construction capital expenditures and the risk of startup defaults. Construction is outsourced to contractors under strict SLA control. The price-to-book value multiple demonstrates a market revaluation of assets, with the indicator currently at 0.48. The fund's slow growth is offset by reliable long-term contracts that ensure a stable stream of net income.

This metric reflects the market revaluation of net assets, allowing for an assessment of the rate of capital premium compression through the ratio of total market capitalization to book value. For Alexandria (ARE), with its unique portfolio of high-tech laboratories, the price-to-book history demonstrates how the reliability of pharmaceutical behemoth tenants supports real estate values above par during periods of market volatility.